A detailed history of Frazier Financial Advisors, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 255 shares of VYGR stock, worth $1,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
255
Previous 156 63.46%
Holding current value
$1,856
Previous $1.23 Million 20.91%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$5.77 - $9.27 $571 - $917
99 Added 63.46%
255 $1.49 Million
Q1 2024

May 13, 2024

BUY
$7.15 - $10.84 $286 - $433
40 Added 34.48%
156 $1.45 Million
Q4 2023

Feb 09, 2024

BUY
$6.28 - $8.81 $728 - $1,021
116 New
116 $980,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $281M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.